Cargando…
Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives
PURPOSE: Precision oncology, such as next generation sequencing (NGS) molecular analysis and bioinformatics are used to guide targeted therapies. The laboratory turnaround time (TAT) is a key performance indicator of laboratory performance. This study aims to formally apply statistical process contr...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498582/ https://www.ncbi.nlm.nih.gov/pubmed/34631570 http://dx.doi.org/10.3389/fonc.2021.736265 |
_version_ | 1784580194569289728 |
---|---|
author | Jain, Sneha Rajiv Sim, Wilson Ng, Cheng Han Chin, Yip Han Lim, Wen Hui Syn, Nicholas L. Kamal, Nur Haidah Bte Ahmad Gupta, Mehek Heong, Valerie Lee, Xiao Wen Sapari, Nur Sabrina Koh, Xue Qing Isa, Zul Fazreen Adam Ho, Lucius O’Hara, Caitlin Ulagapan, Arvindh Gu, Shi Yu Shroff, Kashyap Weng, Rei Chern Lim, Joey S. Y. Lim, Diana Pang, Brendan Ng, Lai Kuan Wong, Andrea Soo, Ross Andrew Yong, Wei Peng Chee, Cheng Ean Lee, Soo-Chin Goh, Boon-Cher Soong, Richie Tan, David S.P. |
author_facet | Jain, Sneha Rajiv Sim, Wilson Ng, Cheng Han Chin, Yip Han Lim, Wen Hui Syn, Nicholas L. Kamal, Nur Haidah Bte Ahmad Gupta, Mehek Heong, Valerie Lee, Xiao Wen Sapari, Nur Sabrina Koh, Xue Qing Isa, Zul Fazreen Adam Ho, Lucius O’Hara, Caitlin Ulagapan, Arvindh Gu, Shi Yu Shroff, Kashyap Weng, Rei Chern Lim, Joey S. Y. Lim, Diana Pang, Brendan Ng, Lai Kuan Wong, Andrea Soo, Ross Andrew Yong, Wei Peng Chee, Cheng Ean Lee, Soo-Chin Goh, Boon-Cher Soong, Richie Tan, David S.P. |
author_sort | Jain, Sneha Rajiv |
collection | PubMed |
description | PURPOSE: Precision oncology, such as next generation sequencing (NGS) molecular analysis and bioinformatics are used to guide targeted therapies. The laboratory turnaround time (TAT) is a key performance indicator of laboratory performance. This study aims to formally apply statistical process control (SPC) methods such as CUSUM and EWMA to a precision medicine programme to analyze the learning curves of NGS and bioinformatics processes. PATIENTS AND METHODS: Trends in NGS and bioinformatics TAT were analyzed using simple regression models with TAT as the dependent variable and chronologically-ordered case number as the independent variable. The M-estimator “robust” regression and negative binomial regression were chosen to serve as sensitivity analyses to each other. Next, two popular statistical process control (SPC) approaches which are CUSUM and EWMA were utilized and the CUSUM log-likelihood ratio (LLR) charts were also generated. All statistical analyses were done in Stata version 16.0 (StataCorp), and nominal P < 0.05 was considered to be statistically significant. RESULTS: A total of 365 patients underwent successful molecular profiling. Both the robust linear model and negative binomial model showed statistically significant reductions in TAT with accumulating experience. The EWMA and CUSUM charts of overall TAT largely corresponded except that the EWMA chart consistently decreased while the CUSUM analyses indicated improvement only after a nadir at the 82(nd) case. CUSUM analysis found that the bioinformatics team took a lower number of cases (54 cases) to overcome the learning curve compared to the NGS team (85 cases). CONCLUSION: As NGS and bioinformatics lead precision oncology into the forefront of cancer management, characterizing the TAT of NGS and bioinformatics processes improves the timeliness of data output by potentially spotlighting problems early for rectification, thereby improving care delivery. |
format | Online Article Text |
id | pubmed-8498582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84985822021-10-09 Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives Jain, Sneha Rajiv Sim, Wilson Ng, Cheng Han Chin, Yip Han Lim, Wen Hui Syn, Nicholas L. Kamal, Nur Haidah Bte Ahmad Gupta, Mehek Heong, Valerie Lee, Xiao Wen Sapari, Nur Sabrina Koh, Xue Qing Isa, Zul Fazreen Adam Ho, Lucius O’Hara, Caitlin Ulagapan, Arvindh Gu, Shi Yu Shroff, Kashyap Weng, Rei Chern Lim, Joey S. Y. Lim, Diana Pang, Brendan Ng, Lai Kuan Wong, Andrea Soo, Ross Andrew Yong, Wei Peng Chee, Cheng Ean Lee, Soo-Chin Goh, Boon-Cher Soong, Richie Tan, David S.P. Front Oncol Oncology PURPOSE: Precision oncology, such as next generation sequencing (NGS) molecular analysis and bioinformatics are used to guide targeted therapies. The laboratory turnaround time (TAT) is a key performance indicator of laboratory performance. This study aims to formally apply statistical process control (SPC) methods such as CUSUM and EWMA to a precision medicine programme to analyze the learning curves of NGS and bioinformatics processes. PATIENTS AND METHODS: Trends in NGS and bioinformatics TAT were analyzed using simple regression models with TAT as the dependent variable and chronologically-ordered case number as the independent variable. The M-estimator “robust” regression and negative binomial regression were chosen to serve as sensitivity analyses to each other. Next, two popular statistical process control (SPC) approaches which are CUSUM and EWMA were utilized and the CUSUM log-likelihood ratio (LLR) charts were also generated. All statistical analyses were done in Stata version 16.0 (StataCorp), and nominal P < 0.05 was considered to be statistically significant. RESULTS: A total of 365 patients underwent successful molecular profiling. Both the robust linear model and negative binomial model showed statistically significant reductions in TAT with accumulating experience. The EWMA and CUSUM charts of overall TAT largely corresponded except that the EWMA chart consistently decreased while the CUSUM analyses indicated improvement only after a nadir at the 82(nd) case. CUSUM analysis found that the bioinformatics team took a lower number of cases (54 cases) to overcome the learning curve compared to the NGS team (85 cases). CONCLUSION: As NGS and bioinformatics lead precision oncology into the forefront of cancer management, characterizing the TAT of NGS and bioinformatics processes improves the timeliness of data output by potentially spotlighting problems early for rectification, thereby improving care delivery. Frontiers Media S.A. 2021-09-24 /pmc/articles/PMC8498582/ /pubmed/34631570 http://dx.doi.org/10.3389/fonc.2021.736265 Text en Copyright © 2021 Jain, Sim, Ng, Chin, Lim, Syn, Kamal, Gupta, Heong, Lee, Sapari, Koh, Isa, Ho, O’Hara, Ulagapan, Gu, Shroff, Weng, Lim, Lim, Pang, Ng, Wong, Soo, Yong, Chee, Lee, Goh, Soong and Tan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Jain, Sneha Rajiv Sim, Wilson Ng, Cheng Han Chin, Yip Han Lim, Wen Hui Syn, Nicholas L. Kamal, Nur Haidah Bte Ahmad Gupta, Mehek Heong, Valerie Lee, Xiao Wen Sapari, Nur Sabrina Koh, Xue Qing Isa, Zul Fazreen Adam Ho, Lucius O’Hara, Caitlin Ulagapan, Arvindh Gu, Shi Yu Shroff, Kashyap Weng, Rei Chern Lim, Joey S. Y. Lim, Diana Pang, Brendan Ng, Lai Kuan Wong, Andrea Soo, Ross Andrew Yong, Wei Peng Chee, Cheng Ean Lee, Soo-Chin Goh, Boon-Cher Soong, Richie Tan, David S.P. Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives |
title | Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives |
title_full | Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives |
title_fullStr | Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives |
title_full_unstemmed | Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives |
title_short | Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives |
title_sort | statistical process control charts for monitoring next-generation sequencing and bioinformatics turnaround in precision medicine initiatives |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498582/ https://www.ncbi.nlm.nih.gov/pubmed/34631570 http://dx.doi.org/10.3389/fonc.2021.736265 |
work_keys_str_mv | AT jainsneharajiv statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT simwilson statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT ngchenghan statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT chinyiphan statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT limwenhui statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT synnicholasl statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT kamalnurhaidahbteahmad statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT guptamehek statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT heongvalerie statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT leexiaowen statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT saparinursabrina statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT kohxueqing statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT isazulfazreenadam statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT holucius statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT oharacaitlin statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT ulagapanarvindh statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT gushiyu statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT shroffkashyap statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT wengreichern statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT limjoeysy statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT limdiana statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT pangbrendan statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT nglaikuan statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT wongandrea statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT soorossandrew statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT yongweipeng statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT cheechengean statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT leesoochin statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT gohbooncher statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT soongrichie statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives AT tandavidsp statisticalprocesscontrolchartsformonitoringnextgenerationsequencingandbioinformaticsturnaroundinprecisionmedicineinitiatives |